Anavex Life Sciences Corp (AVXL)

[TempePhil]

Anavex's CTAD presentation will be...
Anavex only has 15 minutes to present PDD data, and it must be related to AD, as it is an AD conference. So they will have be concise and AD relevant.

After very brief company introduction, the presentation will introduce A2-73 and briefly discuss it's MOA using the S1 receptor. The discussion will quickly turn to AD. The famous A/D trial 'sub-group' slide will be shown, explaining the various sub-group responses. At some point, maybe here, they will tie the AD dementia to PD dementia.

A similar slide will be presented showing the PDD 'sub-groups', describing how closely it matches the AD sub-groups. Neatly connecting the two dementias as maybe the same.
Possibly a brief mention that the MOA is applicable to many CNS diseases.

End of presentation.

STUNNED AUDIENCE begins to realize the have just witnessed breakthrough science in their field.
Q&A session: Silence. (Audience) Uhhhh...let me think about this for a minute.



All IMHO.